OBJECTIVE: Angelman syndrome (AS) is a neurodevelopmental disorder caused by a deletion on chromosome 15, uniparental disomy, imprinting defect, or UBE3A mutation. It is characterized by intellectual disability with minimal speech and certain behavioral characteristics. We used standardized measures to characterize the developmental profile and to analyze genotype-phenotype correlations in AS. METHOD: The study population consisted of 92 children, between 5 months and 5 years of age, enrolled in a Natural History Study. Each participant was evaluated using the Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III), the Vineland Adaptive Behavior Scales, Second Edition (VABS-II), and the Aberrant Behavior Checklist. RESULTS: Seventy-four percent had a deletion and 26% had uniparental disomy, an imprinting defect or a UBE3A mutation ("non-deletion"). The mean +/- standard deviation BSID-III cognitive scale developmental quotient (DQ) was 40.5 +/- 15.5. Participants with deletions were more developmentally delayed than the non-deletion participants in all BSID-III domains except in expressive language skills. The cognitive DQ was higher than the DQ in each of the other domains, and the receptive language DQ was higher than the expressive language DQ. In the [ corrected] VABS-II, deletion participants had weaker motor and language skills than the non-deletion participants. CONCLUSION: Children with AS have a distinct developmental and behavioral profile; their cognitive skills are stronger than their language and motor skills, and their receptive language skills are stronger than expressive language skills. Developmental outcomes are associated with genotype, with deletion patients having worse outcomes than non-deletion patients.
OBJECTIVE:Angelman syndrome (AS) is a neurodevelopmental disorder caused by a deletion on chromosome 15, uniparental disomy, imprinting defect, or UBE3A mutation. It is characterized by intellectual disability with minimal speech and certain behavioral characteristics. We used standardized measures to characterize the developmental profile and to analyze genotype-phenotype correlations in AS. METHOD: The study population consisted of 92 children, between 5 months and 5 years of age, enrolled in a Natural History Study. Each participant was evaluated using the Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III), the Vineland Adaptive Behavior Scales, Second Edition (VABS-II), and the Aberrant Behavior Checklist. RESULTS: Seventy-four percent had a deletion and 26% had uniparental disomy, an imprinting defect or a UBE3A mutation ("non-deletion"). The mean +/- standard deviation BSID-III cognitive scale developmental quotient (DQ) was 40.5 +/- 15.5. Participants with deletions were more developmentally delayed than the non-deletion participants in all BSID-III domains except in expressive language skills. The cognitive DQ was higher than the DQ in each of the other domains, and the receptive language DQ was higher than the expressive language DQ. In the [ corrected] VABS-II, deletion participants had weaker motor and language skills than the non-deletion participants. CONCLUSION:Children with AS have a distinct developmental and behavioral profile; their cognitive skills are stronger than their language and motor skills, and their receptive language skills are stronger than expressive language skills. Developmental outcomes are associated with genotype, with deletion patients having worse outcomes than non-deletion patients.
Authors: T Sahoo; S U Peters; N S Madduri; D G Glaze; J R German; L M Bird; R Barbieri-Welge; T J Bichell; A L Beaudet; C A Bacino Journal: J Med Genet Date: 2005-09-23 Impact factor: 6.318
Authors: A C Lossie; M M Whitney; D Amidon; H J Dong; P Chen; D Theriaque; A Hutson; R D Nicholls; R T Zori; C A Williams; D J Driscoll Journal: J Med Genet Date: 2001-12 Impact factor: 6.318
Authors: U Albrecht; J S Sutcliffe; B M Cattanach; C V Beechey; D Armstrong; G Eichele; A L Beaudet Journal: Nat Genet Date: 1997-09 Impact factor: 38.330
Authors: Jane E Roberts; Jean B Mankowski; John Sideris; Barbara Davis Goldman; Deborah D Hatton; Penny L Mirrett; Grace T Baranek; J Steven Reznick; Anna C J Long; Donald B Bailey Journal: J Pediatr Psychol Date: 2008-12-12
Authors: David Hessl; Danh V Nguyen; Cherie Green; Alyssa Chavez; Flora Tassone; Randi J Hagerman; Damla Senturk; Andrea Schneider; Amy Lightbody; Allan L Reiss; Scott Hall Journal: J Neurodev Disord Date: 2009-03 Impact factor: 4.025
Authors: Wen-Hann Tan; Carlos A Bacino; Steven A Skinner; Irina Anselm; Rene Barbieri-Welge; Astrid Bauer-Carlin; Arthur L Beaudet; Terry Jo Bichell; Jennifer K Gentile; Daniel G Glaze; Lucia T Horowitz; Sanjeev V Kothare; Hye-Seung Lee; Mark P Nespeca; Sarika U Peters; Trilochan Sahoo; Dean Sarco; Susan E Waisbren; Lynne M Bird Journal: Am J Med Genet A Date: 2011-01 Impact factor: 2.802
Authors: Wen-Hann Tan; Lynne M Bird; Anjali Sadhwani; Rene L Barbieri-Welge; Steven A Skinner; Lucia T Horowitz; Carlos A Bacino; Lisa M Noll; Cary Fu; Rachel J Hundley; Logan K Wink; Craig A Erickson; Gregory N Barnes; Anne Slavotinek; Rita Jeremy; Alexander Rotenberg; Sanjeev V Kothare; Heather E Olson; Annapurna Poduri; Mark P Nespeca; Hillary C Chu; Jennifer M Willen; Kevin F Haas; Edwin J Weeber; Paul A Rufo Journal: Am J Med Genet A Date: 2017-09-25 Impact factor: 2.802
Authors: Hsien-Sung Huang; Andrew J Burns; Randal J Nonneman; Lorinda K Baker; Natallia V Riddick; Viktoriya D Nikolova; Thorfinn T Riday; Koji Yashiro; Benjamin D Philpot; Sheryl S Moy Journal: Behav Brain Res Date: 2013-01-04 Impact factor: 3.332
Authors: Matthew C Judson; Jason O Sosa-Pagan; Wilmer A Del Cid; Ji Eun Han; Benjamin D Philpot Journal: J Comp Neurol Date: 2014-06-01 Impact factor: 3.215